Come up with a name for your new list and we'll add to it:
AbVitro was acquired by
Juno Therapeutics on January 11, 2016.
AbVitro's cutting edge technology platform accelerates the development of novel immunotherapies by identifying cancer-specific immune cells from natural immune responses at unprecedented resolution. B…